Comprehensive examinations of 143 refugee patients hailing mostly from Afghanistan and Syria, which were conducted between June and December 2015, showed a high prevalence of MRSA, ESBL and MDRGN upon hospital admission. The figures exceed not only those of the general population but, alarmingly, also those found in high-risk groups, such as residents of nursing homes or home care service…
Research at the University of Konstanz has identified a molecule that allows the bacterium Pseudomonas aeruginosa to inhibit its rival, Staphylococcus aureus. This might build the basis for the development of new antibiotics.
Nemus Bioscience and the University of Mississippi report significant anti-MRSA synergy data utilizing proprietary cannabinoid-based anti-infective platforms.
Adding UV light to standard cleaning cut transmission of 4 resistant bacteria by 30 percent
Airports are international travel hubs visited by large numbers of people. London Heathrow, for example, has an average of 205,400 travellers every day and saw 75 million people arriving and departing from all over the world in 2015. A study just published in the journal Clinical Microbiology and Infection suggest that international travellers can acquire antimicrobial-resistant bacteria and may…
Researchers have discovered that secondary infection with the Methicillin-resistant Staphylococcus aureus (MRSA) bacterium (or “superbug”) often kills influenza patients because the flu virus alters the antibacterial response of white blood cells, causing them to damage the patients’ lungs instead of destroying the bacterium. The study suggests that inhibiting this response may help treat…
Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have found that the breast cancer drug tamoxifen gives white blood cells a boost, better enabling them to respond to, ensnare and kill bacteria in laboratory experiments. Tamoxifen treatment in mice also enhances clearance of the antibiotic-resistant bacterial pathogen…
MRSA is bad news. If you've never heard of it, here's what you need to know: It's pronounced MER-suh, it's a nasty bacterial infection and it can cause serious disease and death. Senior molecular biology major Jacob Hatch knows MRSA as the infection that took his dad's leg.
A first of its kind expert consensus report on Clostridium difficile infection (CDI), contributed to by more than 1,000 healthcare professionals across Europe, has been presented today at the Healthcare Infection Society (HIS) International Congress in Lyon, France. The consensus report aimed to identify a set of expert views on CDI management, in order to determine attitudes to diagnosis,…
While the Generating Antibiotic Incentives Now (GAIN) Act of 2012 has been a significant step in the right direction for encouraging novel antibiotics research, the US Food and Drug Administration (FDA) remains one step behind its European equivalent, the European Medicines Agency (EMA), according to an analyst with research and consulting firm GlobalData.
The GenSPEED Test System developed by Greiner Bio-One combines crude lysis of bacteria with multiplex-PCR before the final automated analysis of PCR-products in the new GenSPEED R2 device.
Ahead of the Irish Infection Prevention Control Conference to be held in Portlaoise on 16 May 2014, Advanced Sterilization Products (ASP), a Division of Ethicon, Inc., a Johnson & Johnson company, is calling on Irish healthcare practitioners to consider the significant economic burden of Healthcare Associated Infections (HAIs) on hospitals, the Health Service Executive (HSE) and the wider…
A one-day course on Infection Prevention and Control (20 November. 9.30 a.m. - 6.00 p.m.) will focus on a vital issue at the Medica Education Conference 2013.
Decontaminating every patient in an intensive care unit is a far more effective approach to controlling infections in hospitals, according to a new study, Mark Nicholls reports.
The properties of copper in helping prevent nosocomial infections were debated this October at the Infection Prevention 2013 conference, when Professor Tom Elliott, Consultant Microbiologist at University Hospitals Birmingham NHS Foundation Trust, addressed the question: ‘Can the use of copper help prevent infection?’
Internet-based training for clinicians could help lower antibiotic prescribing rates for acute respiratory tract infections by as much as 62%, according to British researchers.
Patients' pathogen acquisition was reduced with Chlorhexidine gluconate 2% w/v impregnated pad, and intranasal mupirocin ointment - Study published in New England Journal of Medicine confirms universal decolonization of ICU patients reduces bloodstream infections by 44%.
A new test gives reliable results in just 75 minutes, speeding up combat actions. Since Methicillin-resistant staphy lococcus aureus (MRSA) has developed resistance to antibiotic treatments, infections have become a dreaded occurrence in hospitals worldwide.
‘This is a dramatic demonstration that medical genomics is no longer a technology of the future – it is a technology of the here and now' Report: Mark Nicholls
A recent webinar, hosted by the American Association of Clinical Chemistry, featured doctors Duane Newton of the University of Michigan and Susan Novak-Weekly of Kaiser Permanente.
The use of in-line filters for infusion therapy significantly lowers the rate of severe complications in children aged between 0-18 years being treated in intensive care units, according to a new study from the Paediatrics Clinic at Hannover Medical School (MHH). The study also confirmed that the number of cases of systemic inflammatory response syndrome, SIRS, dropped substantially through the…
As in so many European countries, nosocomial infections have hit the headlines in Germany over and over again in recent years – as when three premature babies died in a Bremen neonatal clinic in 2011.
Hospital acquired infections (HAIs) are among the most common complications during a hospital and care home stay in the West (although they also occur in developing countries, with even an assumed higher incidence), causing enormous strain for those affected as well as high follow-on costs for healthcare systems.
Scientists state concern for both human and environmental health from a very commonly used antibacterial/antifungal agent. Brenda Marsh reports